Novel Inhibitors of Peptidoglycan Biosynthesis Targeting Gram-positive Pathogens
Novel Inhibitors of Peptidoglycan Biosynthesis Targeting Gram-positive Pathogens
批准号:
9330172
负责人:
Michael S VanNieuwenhze
金额:
$34.71万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-09-01 至 2019-08-31
关键词:
AddressAffinityAnabolismAntibioticsBacteriaBindingBinding SitesBiochemicalBiologicalCell WallCellsCellular StructuresChemicalsCollaborationsComplexDataDepsipeptidesDevelopmentEvaluationGlycopeptide AntibioticsGlycopeptidesInfectionInvestigationIsotope LabelingLactamsLettersLipidsMapsMeasurementMolecular ConformationMolecular TargetPathway interactionsPeptidesPeptidoglycanPharmaceutical PreparationsPharmacologic SubstancePositioning AttributeProlinePublic HealthReactionRecyclingResearchResistanceSeriesSodium ChlorideStaphylococcus aureusStructureStructure-Activity RelationshipTherapeutic AgentsUrsidae FamilyVancomycinanalogbacterial resistancebasechemical synthesischemotherapeutic agentcomputer studiesdrug structureempedopeptinexperimental studyinhibitor/antagonistinsightmolecular dynamicsnovelpathogenprofessorpublic health relevanceresponsescaffoldscreeningsolid statethree dimensional structuretool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The proposed research involves synthesis and study of lipodepsipeptide antibiotics that possess excellent biological activity versus Gram-positive positive bacteria, including problematic resistant pathogens. The lipodepsipeptide antibiotics under study are believed to manifest their biological activity through inhibition of the transglycosylation reaction, a key late stage transformation in the peptidoglycan biosynthetic pathway. In addition, the inhibition of lipid recycling may also contribute to the observed biological activity. The proposed research seeks to identify novel chemical entities to be used for the treatment of Gram-positive infections and, in particular, infections due to problematic resistant Gram-positive pathogens.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1016/j.tcsw.2018.04.002
发表时间:
2018-06
期刊:
Cell surface (Amsterdam, Netherlands)
影响因子:
--
作者:
[Hernández-Rocamora VM, Otten CF, Radkov A, Simorre JP, Breukink E, VanNieuwenhze M, Vollmer W]
通讯作者:
Vollmer W
Dual Mode of Action for Plusbacin A3 in Staphylococcus aureus.
Plusbacin A3 对金黄色葡萄球菌的双重作用模式。
DOI:
10.1021/acs.jpcb.6b11039
发表时间:
2017
期刊:
The journal of physical chemistry. B
影响因子:
--
作者:
[O'Connor,RobertD, Singh,Manmilan, Chang,James, Kim,SungJoon, VanNieuwenhze,Michael, Schaefer,Jacob]
通讯作者:
Schaefer,Jacob
Z-ring membrane anchors associate with cell wall synthases to initiate bacterial cell division.
Z形膜锚固型与细胞壁合酶相关,以启动细菌细胞分裂。
DOI:
10.1038/s41467-018-07559-2
发表时间:
2018-11-30
期刊:
Nature communications
影响因子:
16.6
作者:
[Pazos M, Peters K, Casanova M, Palacios P, VanNieuwenhze M, Breukink E, Vicente M, Vollmer W]
通讯作者:
Vollmer W
Chemical Biology Studies of the Dynamics and Inhibition of Peptidoglycan Biosynthesis
-
批准号:10343788
-
项目类别:
-
资助金额:$37.56万
-
财政年份:2020
-
负责人:Michael S VanNieuwenhze
-
依托单位:
Chemical Biology Studies of the Dynamics and Inhibition of Peptidoglycan Biosynthesis
-
批准号:10597980
-
项目类别:
-
资助金额:$37.56万
-
财政年份:2020
-
负责人:Michael S VanNieuwenhze
-
依托单位:
Supplement to Chemical Biology Studies of the Dynamics and Inhibition of Peptidoglycan Biosynthesis
-
批准号:10609340
-
项目类别:
-
资助金额:$13.89万
-
财政年份:2020
-
负责人:Michael S VanNieuwenhze
-
依托单位:
Novel Inhibitors of Peptidoglycan Biosynthesis Targeting Gram-positive Pathogens
-
批准号:8749603
-
项目类别:
-
资助金额:$34.71万
-
财政年份:2014
-
负责人:Michael S VanNieuwenhze
-
依托单位:
Novel Inhibitors of Peptidoglycan Biosynthesis Targeting Gram-positive Pathogens
-
批准号:8913230
-
项目类别:
-
资助金额:$34.71万
-
财政年份:2014
-
负责人:Michael S VanNieuwenhze
-
依托单位:
Synthesis and Mechanistic Studies of Peptide Antibiotics
-
批准号:7149128
-
项目类别:
-
资助金额:$11.97万
-
财政年份:2004
-
负责人:Michael S VanNieuwenhze
-
依托单位:
Synthesis and Mechanistic Studies of Peptide Antibiotics
-
批准号:6868727
-
项目类别:
-
资助金额:$23.47万
-
财政年份:2004
-
负责人:Michael S VanNieuwenhze
-
依托单位:
Synthesis and Mechanistic Studies of Peptide Antibiotics
-
批准号:7317819
-
项目类别:
-
资助金额:$30.46万
-
财政年份:2004
-
负责人:Michael S VanNieuwenhze
-
依托单位:
Synthesis and Mechanistic Studies of Peptide Antibiotics
-
批准号:7546992
-
项目类别:
-
资助金额:$30.35万
-
财政年份:2004
-
负责人:Michael S VanNieuwenhze
-
依托单位:
Synthesis and Mechanistic Studies of Peptide Antibiotics
-
批准号:7516583
-
项目类别:
-
资助金额:$20.26万
-
财政年份:2004
-
负责人:Michael S VanNieuwenhze
-
依托单位:
Synthesis and Mechanistic Studies of Peptide Antibiotics
-
批准号:6986205
-
项目类别:
-
资助金额:$34.28万
-
财政年份:2004
-
负责人:Michael S VanNieuwenhze
-
依托单位:
Synthesis and Mechanistic Studies of Peptide Antibiotics
-
批准号:6759683
-
项目类别:
-
资助金额:$35.23万
-
财政年份:2004
-
负责人:Michael S VanNieuwenhze
-
依托单位:
CORE Fb
-
批准号:7531125
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2003
-
负责人:Michael S VanNieuwenhze
-
依托单位:
EPOXIDATIONS WITH CHIRALLY MODIFIED RU(V)-OXO COMPLEXES
-
批准号:2169827
-
项目类别:
-
资助金额:$2.16万
-
财政年份:1993
-
负责人:Michael S VanNieuwenhze
-
依托单位:
EPOXIDATIONS WITH CHIRALLY MODIFIED RU(V)-OXO COMPLEXES
-
批准号:2169828
-
项目类别:
-
资助金额:$1.09万
-
财政年份:1993
-
负责人:Michael S VanNieuwenhze
-
依托单位:
CORE Fb
-
批准号:7551352
-
项目类别:
-
资助金额:$24.19万
-
财政年份:--
-
负责人:Michael S VanNieuwenhze
-
依托单位:
Core F(B): Synthesis Design
-
批准号:8130689
-
项目类别:
-
资助金额:$46.51万
-
财政年份:--
-
负责人:Michael S VanNieuwenhze
-
依托单位:
CORE Fb
-
批准号:7551318
-
项目类别:
-
资助金额:$18.2万
-
财政年份:--
-
负责人:Michael S VanNieuwenhze
-
依托单位:
CORE Fb
-
批准号:7551335
-
项目类别:
-
资助金额:$19.2万
-
财政年份:--
-
负责人:Michael S VanNieuwenhze
-
依托单位:
Core F(B): Synthesis Design
-
批准号:7932731
-
项目类别:
-
资助金额:$46.87万
-
财政年份:--
-
负责人:Michael S VanNieuwenhze
-
依托单位:
海外基金